Butorphanol Nasal Spray
Covers medical necessity and prior authorization criteria for butorphanol tartrate nasal spray for management of severe pain when alternatives are inadequate; applies to members under Centene-affiliated health plans (HIM line of business).
Added option to bypass redirection if prescribed by or in consultation with a pain management specialist or an oncologist; added bypass for use in palliative care or hospice care.
Coverage Criteria
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.